Table 1.

Characteristics of Persons With Diagnosed Human Immunodeficiency Virus (HIV) Infection With and Without an Eligible HIV-1 Nucleotide Sequence: 28 US States, 2014–2018

	New HIV Diagnoses With an Eligible Sequence		New HIV Diagnoses Without an Eligible Sequence
Characteristics	n	%	n	%
Total	50 747	100.0	92 662	100.0
Sex at birth
Female	8636	17.0	17 840	19.3
Male	42 111	83.0	74 822	80.7
Age at HIV diagnosis
13–29 years	21 031	41.4	37 922	40.9
30–49 years	21 131	41.6	39 187	42.3
≥50 years	8585	16.9	15 553	16.8
Race/ethnicity
Black/African American	19 463	38.4	37 807	40.8
Hispanic/Latino	14 731	29.0	26 450	28.5
White	13 392	26.4	22 351	24.1
Other	3161	6.2	6054	6.5
Transmission category
Male-to-male sexual contact	35 111	69.2	60 895	65.7
IDU	2617	5.2	5585	6.0
Male-to-male sexual contact and IDU	1793	3.5	3321	3.6
Heterosexual contact	11 153	22.0	22 680	24.5
Other	72	0.1	181	0.2
US Census region
Northeast	8189	16.1	13 226	14.3
Midwest	6134	12.1	11 575	12.5
South	23 881	47.1	45 652	49.3
West	12 543	24.7	22 209	24.0
Year of HIV diagnosis
2014	9395	18.5	20 342	22.0
2015	9575	18.9	19 667	21.2
2016	10 923	21.5	18 215	19.7
2017	10 892	21.5	17 115	18.5
2018	9962	19.6	17 323	18.7
Stage of HIV infection at diagnosis
Stage 1	13 202	26.0	21 838	23.6
Stage 2	18 234	35.9	24 057	26.0
Stage 3 (AIDS)	13 059	25.7	17 378	18.8
Stage unknown	6252	12.3	29 389	31.7

Abbreviation: IDU, injection drug use.